Results 1 to 10 of about 16,990 (173)

Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer’s disease retina [PDF]

Nature Communications
Chlamydia pneumoniae is an intracellular bacterium implicated in Alzheimer’s disease (AD), but its role in retinal pathology and disease progression is unclear.
Bhakta Prasad Gaire, Yosef Koronyo, Jean-Philippe Vit, Alexandre Hutton, Lalita Subedi, Dieu-Trang Fuchs, Natalie Swerdlow, Altan Rentsendorj, Saba Shahin, Daisy Martinon, Edward Robinson, Alexander V. Ljubimov, Julie A. Schneider, Lon S. Schneider, Debra Hawes, Stuart L. Graham, Vivek K. Gupta, Mehdi Mirzaei, Keith L. Black, Jesse G. Meyer, Moshe Arditi, Timothy R. Crother, Maya Koronyo-Hamaoui   +22 more
doaj   +2 more sources

Establishment and Performance Evaluation of Multiplex PCR-Dipstick DNA Chromatography for Mycoplasma pneumoniae and Chlamydia pneumoniae Rapid Detection [PDF]

Canadian Journal of Infectious Diseases and Medical Microbiology, 2023
Background and Objective. Mycoplasma pneumoniae (MP) and Chlamydia pneumoniae (CP) infections are becoming increasingly prominent in respiratory infections.
Liuyang Hu, Xiuri Wang, Donglin Cao, Qiuchen Cheng, Qiong Li   +4 more
doaj   +2 more sources

HSP60, SP110 and TNF-α expression in Chlamydia pneumoniae-positive versus Chlamydia pneumoniae-negative atherosclerotic plaques

Polish Journal of Pathology, 2022
Traditionally recognized risk factors for atherosclerosis are not presented in 50% of patients with ischemic heart disease. Chronic inflammation with low pathogenic agents with slightly, or no signs of inflammation is the mainstay of atherosclerosis and ...
Nemanja Radojevic, Batric Vukcevic, Andrea Jovovic, Filip Vukmirovic   +3 more
doaj   +1 more source

Identification of Coinfections by Viral and Bacterial Pathogens in COVID-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics

Antibiotics, 2021
The impact of respiratory coinfections in COVID-19 is still not well understood despite the growing evidence that consider coinfections greater than expected.
Giancarlo Pérez-Lazo, Wilmer Silva-Caso, Juana del Valle-Mendoza, Adriana Morales-Moreno, José Ballena-López, Fernando Soto-Febres, Johanna Martins-Luna, Hugo Carrillo-Ng, Luís J. del Valle, Sungmin Kym, Miguel Angel Aguilar-Luis, Issac Peña-Tuesta, Carmen Tinco-Valdez, Luis Ricardo Illescas   +13 more
doaj   +1 more source

Chlamydia pneumoniae (TWAR) [PDF]

Clinical Microbiology Reviews, 1995
Chlamydia pneumoniae (TWAR) is a recently recognized third species of the genus Chlamydia that causes acute respiratory disease. It is distinct from the other two chlamydial species that infect humans, C. trachomatis and C. psittaci, in elementary body morphology and shares less than 10% of the DNA homology with those species. The organism has a global
C C, Kuo, L A, Jackson, L A, Campbell, J T, Grayston   +3 more
openaire   +2 more sources

Identification of Co-Infections by Viral and Bacterial Pathogens in Covid-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics

International Journal of Infectious Diseases, 2022
Purpose: The impact of respiratory coinfections in COVID-19 is still not well understood. This study sought to identify the respiratory pathogens causing coinfections in patients with moderate/severe SARS-CoV-2 pneumonia from a hospital in Peru. Also, to
G. Pérez-Lazo, W. Silva-Caso, J. Del Valle-Mendoza, A. Morales-Moreno, M.A. Aguilar-Luis, F. Soto-Febres, H. Carrillo-Ng, L.J. Del Valle, C. Tinco-Valdez, J. Martins-Luna, I. Peña-Tuesta, J. Ballena-López, L.R. Illescas   +12 more
doaj   +1 more source

Chlamydia pneumoniae

Journal of Antimicrobial Chemotherapy, 1994
Chlamydia pneumoniae, a fairly recent addition to the genus Chlamydia, has been shown to cause community-acquired and nosocomial pneumonias, and to be a common infectious agent in human populations throughout the world. It has a wide variety of clinical presentations, and may be associated with ischaemic heart disease.
P J, Cook, D, Honeybourne
  +6 more sources

[Chlamydia pneumoniae]. [PDF]

Ugeskrift for laeger, 1993
Chlamydia are obligate intracellular bacteria with a biphasic life cycle. In 1986 a new species of Chlamydiae, Chlamydia psittaci TWAR was discovered, later named Chlamydia pneumoniae. C. pneumoniae is probably an important pathogen causing respiratory tract infections in man, ranging from subclinical infection to life threatening pneumonia. Infections
L J, Ostergaard, S B, Andersen, G, Christiansen, P L, Andersen   +3 more
  +7 more sources

Prediction of Chlamydia pneumoniae protein localization in host mitochondria and cytoplasm and possible involvements in lung cancer etiology: a computational approach

Saudi Pharmaceutical Journal, 2017
Collecting evidence suggests that the intercellular infection of Chlamydia pneumoniae in lungs contributes to the etiology of lung cancer. Many proteins of Chlamydia pneumoniae outmanoeuvre the various system of the host.
Aws Alshamsan, Shahanavaj Khan, Ahamad Imran, Ibrahim A. Aljuffali, Khalid Alsaleh   +4 more
doaj   +1 more source

Chlamydia pneumoniae and symptomatic carotid atherosclerotic plaque: a prospective study Chlamydia pneumoniae e placa aterosclerótica sintomática de carótida: um estudo prospectivo

Arquivos de Neuro-Psiquiatria, 2007
OBJECTIVE: To investigate the possible link between symptomatic carotid atherosclerotic plaque and Chlamydia pneumoniae. BACKGROUND: Recently, several studies have demonstrated that there may be a possible link between Chlamydia pneumonia and carotid ...
Rubens J. Gagliardi, Denise R. Silveira, Roberto A. Caffaro, Vanessa Prado dos Santos, Hélio H. Caiaffa-Filho   +4 more
doaj   +1 more source